Search by Drug Name or NDC

    NDC 66215-0403-01 Veletri 0.5 mg/10mL Details

    Veletri 0.5 mg/10mL

    Veletri is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actelion Pharmaceuticals US, Inc.. The primary component is EPOPROSTENOL.

    Product Information

    NDC 66215-0403
    Product ID 66215-403_39e8b7f8-f82a-4083-a284-ce571a87ce97
    Associated GPIs 40170040102110
    GCN Sequence Number 069964
    GCN Sequence Number Description epoprostenol sodium VIAL 0.5 MG INTRAVEN
    HIC3 B1C
    HIC3 Description PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE
    GCN 33243
    HICL Sequence Number 007323
    HICL Sequence Number Description EPOPROSTENOL SODIUM
    Brand/Generic Brand
    Proprietary Name Veletri
    Proprietary Name Suffix n/a
    Non-Proprietary Name epoprostenol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/10mL
    Substance Name EPOPROSTENOL
    Labeler Name Actelion Pharmaceuticals US, Inc.
    Pharmaceutical Class Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022260
    Listing Certified Through 2024-12-31

    Package

    NDC 66215-0403-01 (66215040301)

    NDC Package Code 66215-403-01
    Billing NDC 66215040301
    Package 1 VIAL in 1 CARTON (66215-403-01) / 10 mL in 1 VIAL
    Marketing Start Date 2010-04-22
    NDC Exclude Flag N
    Pricing Information N/A